Puma SE
OTC:PMMAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma SE
OTC:PMMAF
|
DE |
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
U
|
UBE Corp
DUS:UBE
|
JP |
|
Quanterix Corp
NASDAQ:QTRX
|
US |
|
L
|
Lantheus Holdings Inc
SWB:0L8
|
US |
|
Central Pattana PCL
SET:CPN
|
TH |
|
Sagimet Biosciences Inc
F:0O2
|
US |
Wall St Price Targets
PMMAF Price Targets Summary
Puma SE
According to Wall Street analysts, the average 1-year price target for PMMAF is 34.27 USD with a low forecast of 27.65 USD and a high forecast of 52.26 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PMMAF's stock price target?
Price Target
34.27
USD
According to Wall Street analysts, the average 1-year price target for PMMAF is 34.27 USD with a low forecast of 27.65 USD and a high forecast of 52.26 USD.
What is the Revenue forecast for Puma SE?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Puma SE?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.
